期刊文献+

宋内志贺菌对氟喹诺酮类药物敏感性降低的相关耐药基因研究 被引量:8

Study on the resistance-related genes of Shigella sonnei with decreased susceptibility to fluoroquinolones
原文传递
导出
摘要 目的研究宋内志贺菌对氟喹诺酮类抗菌药物敏感性降低的相关耐药基因的变化情况。方法采用琼脂稀释法对131株宋内志贺菌进行药物敏感性检测,采用PCR法检测DNA旋转酶A亚单位(gyrA)、拓扑异构酶IVC亚单位(parC)基因的喹诺酮类药物耐药决定区(QRDR),并对PCR结果进行测序分析,同时用PCR法对质粒介导喹诺酮类耐药(PMQR)基因(qnr)和氨基糖苷乙酰转移酶变异基因[aac(6’)-Ib-cr]进行筛选。结果131株宋内志贺菌对萘啶酸的耐药率达100%,而对诺氟沙星、环丙沙星、左氧氟沙星全部敏感,对四环素、复方磺胺甲嚼唑和氨苄西林的耐药率分别为93.9%、92.8%和93.2%。94%的萘啶酸耐药宋内志贺菌株对氟喹诺酮类药物敏感性出现下降。萘啶酸耐药菌株gyrA均发生单点83位丝氨酸一亮氨酸(Ser→Leu)突变,但parC未发生突变;未检出qnr和nnc(6’)-Ib-cr基因。结论萘啶酸耐药宋内志贺菌对氟喹诺酮类药物敏感性降低,其产生的主要机制为gYrA发生83位Ser→Leu替换。 Objective To investigate the resistance-related genes of Shigella sonnei with decreased susceptibility to fluoroquinolones. Methods A total of 131 strains of Shigella sonnei were analyzed for their antimicrobial susceptibility. Mutations within the quinolone resistance determining regions (QRDR) of gyrA and parC were detected by polymerase chain reaction (PCR) and PCR products were then sequenced. Meanwhile, the plasmid-mediated quinolone resistance (PMQR)genes, qnr and aac(6')-Ib-cr were screened by PCR. Results Resistance rates of 131 Shigella sonnei isolates to nalidixic acid, tetracycline, ampicillin and trimethoprim-sulfamethoxazole were 100. 0%, 93.9%, 93.2 % and 92.8%, respectively. All strains were susceptible to norfloxaein, ciprofloxacin, levofloxacin, while 94% nalidixic acid-resistant Shigella sonnei strains showed reduced susceptibilities to fluoroquinolones. All of nalidixic acid-resistant Shigella sonnei strains presented a single mutation at codon 83 (Ser→Leu) of gyrA genes, but no mutations were detected in parC gene. And PMQR genes qnr and aac (6')-Ib-cr were not detected. Conclusions The nalidixic acid-resistant Shigella sonnei strains with reduced susceptibility to fluoroquinolones are common in the clinical practice, which may mainly due to a single mutation at codon 83 (Ser→Leu) of gyrA genes.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2012年第2期67-70,共4页 Chinese Journal of Infectious Diseases
基金 卫生部科技重大专项资助项目(2008ZX10004-008)
关键词 志贺菌 宋氏 抗感染药 微生物敏感性试验 DNA促旋酶 DNA拓扑异构酶Ⅳ Shigella sonnei Anti-infective agents Microbial sensitivity tests DNA gyrase DNA topoisomerase IV
  • 相关文献

参考文献20

  • 1Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ, 1999,77:651-666.
  • 2Ashkenazi S, Amir J, Waisman Y, et al. A randomized, double-blind study comparing cefixime and trimethoprimsulfamethoxazole in the treatment of childhood shigellosis. J Pediatr, 1993,123 : 817-821.
  • 3Nelson JD, Kusmiesz H, Jackson LH,et al. Trimethoprim- sulfamethoxazole therapy for shigellosis. JAMA, 1976,235 : 1239-1243.
  • 4Pal SC, Sengupta PG, Sen D, et al. Epidemic shigellosis due to Shigella dysenteriae type 1 in south Asia. Indian J Med Res, 1989,89:57-64.
  • 5Talukder KA, Khajanchi BK, Islam MA, et al. Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia. J Antimicrob Chemother, 2004,54 : 730-734.
  • 6余华丽,常昭瑞,张立实,张静,李振军,徐建国,冉陆.国家监测点2005年志贺菌菌型分布和药敏结果分析[J].中华流行病学杂志,2007,28(4):370-373. 被引量:48
  • 7Acar JF, Goldstein FW. Trends in bacterial resistance tofluoroquinolones, Clin Infect Dis, 1997,24 Suppl 1 : S67-73.
  • 8汪雅萍,应春妹,吴唯一,叶杨芹,张灏旻,于嘉屏.宋内志贺菌对喹诺酮类抗菌药物的耐药性研究[J].中国感染与化疗杂志,2009,9(1):27-31. 被引量:5
  • 9Pu XY, Pan JC, Wang HQ, et al. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother, 2009,63 :917-920.
  • 10Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. CLSI document M100-S20. Wayne: PA, 2010.

二级参考文献18

共引文献107

同被引文献61

  • 1徐婷,黄一灵,李耘,吕媛,夏文颖,顾兵,刘根焰,潘世扬.六家医院整合子介导宋内志贺菌多重耐药的形成和传播机制研究[J].中华临床感染病杂志,2013,6(3):138-143. 被引量:6
  • 2濮小英,潘劲草,孟冬梅,汪皓秋,黄志成,顾亚明.杭州地区1998—2005年志贺菌分子分型及变异研究[J].中华流行病学杂志,2007,28(2):206-207. 被引量:1
  • 3余华丽,常昭瑞,张立实,张静,李振军,徐建国,冉陆.国家监测点2005年志贺菌菌型分布和药敏结果分析[J].中华流行病学杂志,2007,28(4):370-373. 被引量:48
  • 4Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ, 1999, 77:651 666.
  • 5Kuo CY, Su I.H, Perere J, et al. Antimicrobial susceptibility of Shigella isolates in eight Asian countries,2001 2004. J Microbiol ImmunoI Infect, 2008, 41: 107- 111.
  • 6yon Seidlein L, Kim DR, All M, et al. A multicentre study of Shigella diarrhoea in clinical manifestations, 3: e353. six asian countries: disease burden and microbiology. Pl.oS Med, 2006.
  • 7朱德妹,汪复,胡付品,等.20lo年中国CHINET细菌耐药性检测.中国感染与化疗杂志,2011,1l:321-329.
  • 8Thong K L,Hoe S L,Puthucheary S D,et al.Detection of virulence genes in Malaysian Shigella species by multiplex PCR assay[J].BMC Infect Dis,2005,5(1):8.
  • 9Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing;twentieth informational supplement[J].M1O0-S20.CISI,2010.
  • 10Nandy S,Mitra U,Rajendran K,et al.Subtype prevalence,plasmid profiles and growing flu0roquinolone resistance in Shigella from Kolkata,India(2001~2007):a hospital,based study[J].Trop Med Int Health,2010,15:1499-1507.

引证文献8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部